Protara Therapeutics, Inc. (TARA) stock
TARANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.34+0.02 (+0.86%)
Close on Nov 18, 2026Market cap $138.28MP/E –Yield –
Protara Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Protara Therapeutics's market cap was $154.80M on Nov 11, 2026, against $284.77M a year earlier. Over the last 5 years it ranged from $14.08M to $340.81M, with a median of $51.82M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $154.80M | -24.7% |
| 2025 | Dec 31, 2025 | $205.67M | +88.8% |
| 2024 | Dec 31, 2024 | $108.93M | +411.1% |
| 2023 | Dec 29, 2023 | $21.31M | -29.4% |
| 2022 | Dec 30, 2022 | $30.20M | -60.2% |
| 2021 | Dec 31, 2021 | $75.84M | -70.2% |
| 2020 | Dec 31, 2020 | $254.73M | +3072.3% |
| 2019 | Dec 31, 2019 | $8.03M | -81.6% |
| 2018 | Dec 31, 2018 | $43.63M | +30.3% |
| 2017 | Dec 29, 2017 | $33.48M | +6.2% |
| 2016 | Dec 30, 2016 | $31.51M | -87.7% |
| 2015 | Dec 31, 2015 | $255.60M | +10114.7% |
| 2014 | Dec 31, 2014 | $2.50M | – |
See a number that looks wrong?